US Patent Issued to Vira Therapeutics, Boehringer Ingelheim International on Jan. 13 for "VSV chimeric vectors" (Austrian Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,844, issued on Jan. 13, was assigned to Vira Therapeutics GmbH (Rum, Austria) and Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"VSV chimeric vectors" was invented by Tobias Nolden (Innsbruck, Austria), Patrik Erlmann (Innsbruck, Austria), Guido Wollmann (Innsbruck, Austria), Zoltan Banki (Innsbruck, Austria), Bart Spiesschaert (Innsbruck, Austria), Janine Kimpel (Innsbruck, Austria) and Dorothee Von Laer (Innsbruck, Austria).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to VSV chimeric vectors, characterized in that the vectors comprise a gene coding for a glycoprotein GP of the Dandenong virus...